Erlangen

Germany

385 total trials 175 recruiting

Filter these 385 trials by phase, condition, sponsor and more.

Open in Search →

COMPRENDO - A PHASE II OPEN LABEL STUDY FOR THE COMPREHENSIVE ANALYSIS OF PREDICTORS OF THE TREATMENT WITH PEMBROLIZUMAB AND OLAPARIB IN PAT … Ended

2024-519350-37-00 4 patients with unresectable or metastatic HER2 negative breast cancer a

Showing 385–385 of 385 trials